![Synthesis and biological evaluation of the major metabolite of atomoxetine: elucidation of a partial κ-opioid agonist effect - ScienceDirect Synthesis and biological evaluation of the major metabolite of atomoxetine: elucidation of a partial κ-opioid agonist effect - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X04006523-gr4.gif)
Synthesis and biological evaluation of the major metabolite of atomoxetine: elucidation of a partial κ-opioid agonist effect - ScienceDirect
![Norepinephrine Transporter Blockade With Atomoxetine Induces Hypertension in Patients With Impaired Autonomic Function | Hypertension Norepinephrine Transporter Blockade With Atomoxetine Induces Hypertension in Patients With Impaired Autonomic Function | Hypertension](https://www.ahajournals.org/cms/asset/3f3a0cec-83c0-4568-9408-18b1938ad93b/11ff1.jpeg)
Norepinephrine Transporter Blockade With Atomoxetine Induces Hypertension in Patients With Impaired Autonomic Function | Hypertension
![A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder | SpringerLink A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00213-013-2986-z/MediaObjects/213_2013_2986_Fig2_HTML.gif)
A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder | SpringerLink
![Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00702-021-02373-5/MediaObjects/702_2021_2373_Fig1_HTML.png)
Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink
![Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00702-021-02373-5/MediaObjects/702_2021_2373_Fig5_HTML.png)
Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink
![Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00702-021-02373-5/MediaObjects/702_2021_2373_Fig3_HTML.png)
Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink
![Synthesis and biological evaluation of the major metabolite of atomoxetine: elucidation of a partial κ-opioid agonist effect - ScienceDirect Synthesis and biological evaluation of the major metabolite of atomoxetine: elucidation of a partial κ-opioid agonist effect - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X04006523-gr1.gif)
Synthesis and biological evaluation of the major metabolite of atomoxetine: elucidation of a partial κ-opioid agonist effect - ScienceDirect
![Atomoxetine produces oxidative stress and alters mitochondrial function in human neuron-like cells | Scientific Reports Atomoxetine produces oxidative stress and alters mitochondrial function in human neuron-like cells | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-49609-9/MediaObjects/41598_2019_49609_Fig1_HTML.png)
Atomoxetine produces oxidative stress and alters mitochondrial function in human neuron-like cells | Scientific Reports
![Attention deficit hyperactivity disorder and its treatment - Vaughan & Asburys General Ophthalmology, 17th ed. Attention deficit hyperactivity disorder and its treatment - Vaughan & Asburys General Ophthalmology, 17th ed.](https://doctorlib.info/ophthalmology/vaughan-asbury-general-ophthalmology/vaughan-asbury-general-ophthalmology.files/image536.jpg)
Attention deficit hyperactivity disorder and its treatment - Vaughan & Asburys General Ophthalmology, 17th ed.
![Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00702-021-02373-5/MediaObjects/702_2021_2373_Fig2_HTML.png)
Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink
![Synthesis and biological evaluation of the major metabolite of atomoxetine: elucidation of a partial κ-opioid agonist effect - ScienceDirect Synthesis and biological evaluation of the major metabolite of atomoxetine: elucidation of a partial κ-opioid agonist effect - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X04006523-gr2.gif)